Immunovant (IMVT) Return on Capital Employed [ROCE] (2019 - 2026)
Immunovant's Return on Capital Employed [ROCE] came in at -68.42% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 1.51 percentage points from -66.91% a year earlier and down 12.28 percentage points from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Immunovant's Return on Capital Employed [ROCE] was -66.31%, down 3.02 percentage points from FY2025.
- Return on Capital Employed [ROCE] has declined in each of the last four fiscal years, with a five-year change of -21.80 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Capital Employed [ROCE] was -63.29% in FY2025 (-10.20 pp), -53.08% in FY2024 (-2.54 pp), -50.54% in FY2023 (-13.16 pp) and -37.38% in FY2022 (+7.13 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is -95.54% (fiscal Q3 2025) to -26.58% (fiscal Q3 2022).
- Year-over-year, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -4.85 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q3 2026 (a gain of 34.25 percentage points), and the weakest in fiscal Q2 2024 (a drop of 47.95 percentage points).
- Business Quant data shows IMVT's Return on Capital Employed [ROCE] at -56.14% (Q4 2026), -61.29% (Q3 2026) and -82.74% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Immunovant | 6.93 Bn | 6.93 Bn | - | -68.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -68.42% |
| Mar 31, 2026 | -56.14% |
| Dec 31, 2025 | -61.29% |
| Sep 30, 2025 | -82.74% |
| Jun 30, 2025 | -66.91% |
| Mar 31, 2025 | -77.94% |
| Dec 31, 2024 | -95.54% |
| Sep 30, 2024 | -66.40% |
| Jun 30, 2024 | -46.64% |
| Mar 31, 2024 | -40.41% |
| Dec 31, 2023 | -51.98% |
| Sep 30, 2023 | -90.77% |
| Jun 30, 2023 | -74.85% |
| Mar 31, 2023 | -54.40% |
| Dec 31, 2022 | -49.31% |
| Sep 30, 2022 | -42.82% |
| Jun 30, 2022 | -35.70% |
| Mar 31, 2022 | -32.34% |
| Dec 31, 2021 | -26.58% |
| Sep 30, 2021 | -28.65% |
API Access
Immunovant Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();